Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
Not yet recruiting · NCT07709741 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sustained Release Oral Formulation For Treatment Of Parkinsons Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT07709741 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Minnesota | 344 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Minnesota | Minneapolis | United States | 325 |